|
NASDAQ Biotechnology Index
NASDAQ Biotechnology Components Listing and Stocks
The NASDAQ Biotechnology Index (^NBI) includes consist of publicly traded
on the NASDAQ Stock Exchange companies from the Biotechnology and
Pharmaceuticals sectors which meet other eligibility criteria.
NASDAQ Biotechnology Index Components
For the most recent (up to date) list of the NASDAQ Biotechnology index component stocks
listing we may recommend visiting the NASDAQ official web site.
As of September 2008
about 150 biotechnology and pharmaceutical companies are listed in the the
NASDAQ Biotechnology index. Such companies as United Therapeutics Corporation
(UHTR), Genzyme Corporation (GENZ), Cephalon, Inc. (CEPH), Techne Corporation
(TECH) are some of the biggest companies from the index basket.
About United Therapeutic Corporation as registered with U.S. Securities and
Exchange Commission: "We are a biotechnology company focused on the
development and commercialization of unique products to address the unmet
medical needs of patients with chronic and life-threatening cardiovascular and
infectious diseases and cancer. Our key therapeutic platforms are: Prostacyclin
Analogs, which are stable synthetic forms of prostacyclin, an important molecule
produced by the body that has powerful effects on blood vessel health and
function. Our lead prostacyclin analog is Remodulin, a treprostinil-based
compound for the treatment of cardiovascular disease."
About Genzyme Corporation as registered with U.S. Securities and
Exchange Commission: "We are a global biotechnology company dedicated to
making a major impact on the lives of people with serious diseases. Our broad
product and service portfolio is focused on rare disorders, renal diseases,
orthopaedics, organ transplant, diagnostic and predictive testing, and cancer.
We were formed as a Delaware corporation in June 1981 and became a Massachusetts
corporation in 1991. We are organized into six financial reporting units, which
we also consider to be our reporting segments: Renal, which develops,
manufactures and distributes products that treat patients suffering from renal
diseases, including chronic renal failure...."
About Chephalon, Inc.
as registered with U.S. Securities and Exchange Commission: "Cephalon, Inc. is
an international biopharmaceutical company dedicated to the discovery,
development and marketing of innovative products to treat human diseases. We
currently focus our efforts in four core therapeutic areas: central nervous
system ("CNS") disorders, pain, oncology and addiction. In addition to
conducting an active research and development program, we market seven
proprietary products in the United States and numerous products in various
countries throughout Europe. Consistent with our core therapeutic areas, we have
aligned our approximately 690-person U.S. field sales and sales management teams
by area. In Europe, we have a sales and marketing organization numbering
approximately 400 persons that supports our presence in nearly 20 European
countries, including France, the United Kingdom, Germany, Italy and Spain.... "
About Techne Corporation
as registered with U.S. Securities and Exchange Commission: "TECHNE Corporation
and Subsidiaries (the Company) are engaged in the development and manufacture of
biotechnology products and hematology calibrators and controls. These activities
are conducted domestically through its wholly-owned subsidiary, Research and
Diagnostic (R&D) Systems, Inc. Through its wholly-owned U.K. subsidiary, R&D
Systems Europe Ltd. (R&D Europe), the Company distributes biotechnology products
throughout Europe. R&D Systems Europe Ltd. has a sales subsidiary, R&D Systems
GmbH, in Germany and a sales office in France. In late fiscal 2007, the Company
established a subsidiary, R&D Systems China Co. Ltd. (R&D China), in Shanghai,
China, to distribute biotechnology products throughout China. The Company
anticipates fulfilling orders for all third-party Chinese distributors from R&D
China beginning in the second quarter of fiscal 2008."
Start using our Professional Charts
and Make Money with our System!
Sign up for a Free Trial Now!
(credit card not required)
|